108 related articles for article (PubMed ID: 30079960)
41. Impact on response and survival of DNA repair single nucleotide polymorphisms in relapsed or refractory multiple myeloma patients treated with thalidomide.
Cibeira MT; de Larrea CF; Navarro A; Díaz T; Fuster D; Tovar N; Rosiñol L; Monzó M; Bladé J
Leuk Res; 2011 Sep; 35(9):1178-83. PubMed ID: 21435719
[TBL] [Abstract][Full Text] [Related]
42. Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancer.
Lambrechts S; Lambrechts D; Despierre E; Van Nieuwenhuysen E; Smeets D; Debruyne PR; Renard V; Vroman P; Luyten D; Neven P; Amant F; Leunen K; Vergote I;
BMC Pharmacol Toxicol; 2015 Feb; 16():2. PubMed ID: 25881102
[TBL] [Abstract][Full Text] [Related]
43. Association of Allelic Interaction of Single Nucleotide Polymorphisms of Influx and Efflux Transporters Genes With Nonhematologic Adverse Events of Docetaxel in Breast Cancer Patients.
Jabir RS; Ho GF; Annuar MABA; Stanslas J
Clin Breast Cancer; 2018 Oct; 18(5):e1173-e1179. PubMed ID: 29885788
[TBL] [Abstract][Full Text] [Related]
44. Polymorphisms of the drug transporters ABCB1, ABCG2, ABCC2 and ABCC3 and their impact on drug bioavailability and clinical relevance.
Bruhn O; Cascorbi I
Expert Opin Drug Metab Toxicol; 2014 Oct; 10(10):1337-54. PubMed ID: 25162314
[TBL] [Abstract][Full Text] [Related]
45. Association of ABCG2 polymorphism with clinical efficacy of imatinib in patients with gastrointestinal stromal tumor.
Koo DH; Ryu MH; Ryoo BY; Beck MY; Na YS; Shin JG; Lee SS; Kim EY; Kang YK
Cancer Chemother Pharmacol; 2015 Jan; 75(1):173-82. PubMed ID: 25417047
[TBL] [Abstract][Full Text] [Related]
46. High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment.
Davies FE; Rollinson SJ; Rawstron AC; Roman E; Richards S; Drayson M; Child JA; Morgan GJ
J Clin Oncol; 2000 Aug; 18(15):2843-51. PubMed ID: 10920132
[TBL] [Abstract][Full Text] [Related]
47. Methylation status of fragile histidine triad (FHIT) gene and its clinical impact on prognosis of patients with multiple myeloma.
Takada S; Morita K; Hayashi K; Matsushima T; Sawamura M; Murakami H; Nojima Y
Eur J Haematol; 2005 Dec; 75(6):505-10. PubMed ID: 16313263
[TBL] [Abstract][Full Text] [Related]
48. The G-Allele of the PSMA6-8C>G polymorphism is associated with poor outcome in multiple myeloma independently of circulating proteasome serum levels.
Bachmann HS; Novotny J; Sixt S; Liebisch P; Frey UH; Dührsen U; Siffert W; Nückel H
Eur J Haematol; 2010 Aug; 85(2):108-13. PubMed ID: 20408869
[TBL] [Abstract][Full Text] [Related]
49. The CXCL12-3'A allele plays a favourable role in patients with multiple myeloma.
Mazur G; Gębura K; Gieryng A; Butrym A; Wróbel T; Bogunia-Kubik K
Cytokine; 2013 Oct; 64(1):422-6. PubMed ID: 23711392
[TBL] [Abstract][Full Text] [Related]
50. Promoter methylation patterns of ABCB1, ABCC1 and ABCG2 in human cancer cell lines, multidrug-resistant cell models and tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients.
Spitzwieser M; Pirker C; Koblmüller B; Pfeiler G; Hacker S; Berger W; Heffeter P; Cichna-Markl M
Oncotarget; 2016 Nov; 7(45):73347-73369. PubMed ID: 27689338
[TBL] [Abstract][Full Text] [Related]
51. High level of soluble interleukin-2 receptor in serum predicts treatment resistance and poor progression-free survival in multiple myeloma.
Wang L; Wang JH; Liu WJ; Wang WD; Wang H; Chen XQ; Geng QR; Lu Y; Xia ZJ
Ann Hematol; 2017 Dec; 96(12):2079-2088. PubMed ID: 28871325
[TBL] [Abstract][Full Text] [Related]
52. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
[TBL] [Abstract][Full Text] [Related]
53. MDR1 diplotypes as prognostic markers in multiple myeloma.
Maggini V; Buda G; Martino A; Presciuttini S; Galimberti S; Orciuolo E; Barale R; Petrini M; Rossi AM
Pharmacogenet Genomics; 2008 May; 18(5):383-9. PubMed ID: 18408561
[TBL] [Abstract][Full Text] [Related]
54. Could age modify the effect of genetic variants in IL6 and TNF-α genes in multiple myeloma?
Martino A; Buda G; Maggini V; Lapi F; Lupia A; Di Bello D; Orciuolo E; Galimberti S; Barale R; Petrini M; Rossi AM
Leuk Res; 2012 May; 36(5):594-7. PubMed ID: 22387051
[TBL] [Abstract][Full Text] [Related]
55. Genetic variants and multiple myeloma risk: IMMEnSE validation of the best reported associations--an extensive replication of the associations from the candidate gene era.
Martino A; Campa D; Jurczyszyn A; Martínez-López J; Moreno MJ; Varkonyi J; Dumontet C; García-Sanz R; Gemignani F; Jamroziak K; Stępieł A; Jacobsen SE; Andersen V; Jurado M; Landi S; Rossi AM; Lesueur F; Marques H; Dudziński M; Wątek M; Moreno V; Orciuolo E; Petrini M; Reis RM; Ríos R; Sainz J; Vogel U; Buda G; Vangsted AJ; Canzian F
Cancer Epidemiol Biomarkers Prev; 2014 Apr; 23(4):670-4. PubMed ID: 24521996
[TBL] [Abstract][Full Text] [Related]
56. Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex.
Haenisch S; Zimmermann U; Dazert E; Wruck CJ; Dazert P; Siegmund W; Kroemer HK; Warzok RW; Cascorbi I
Pharmacogenomics J; 2007 Feb; 7(1):56-65. PubMed ID: 16788565
[TBL] [Abstract][Full Text] [Related]
57. The effect of salvage autologous stem-cell transplantation on overall survival in patients with relapsed multiple myeloma (final results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial.
Cook G; Ashcroft AJ; Cairns DA; Williams CD; Brown JM; Cavenagh JD; Snowden JA; Parrish C; Yong K; Cavet J; Hunter H; Bird JM; Pratt G; Chown S; Heartin E; O'Connor S; Drayson MT; Hockaday A; Morris TC;
Lancet Haematol; 2016 Jul; 3(7):e340-51. PubMed ID: 27374467
[TBL] [Abstract][Full Text] [Related]
58. Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma.
Rajkumar S; Fonseca R; Lacy M; Witzig T; Lust J; Greipp P; Therneau T; Kyle R; Litzow M; Gertz M
Bone Marrow Transplant; 1999 Sep; 24(5):497-503. PubMed ID: 10482933
[TBL] [Abstract][Full Text] [Related]
59. Once weekly versus twice weekly carfilzomib dosing in patients with relapsed and refractory multiple myeloma (A.R.R.O.W.): interim analysis results of a randomised, phase 3 study.
Moreau P; Mateos MV; Berenson JR; Weisel K; Lazzaro A; Song K; Dimopoulos MA; Huang M; Zahlten-Kumeli A; Stewart AK
Lancet Oncol; 2018 Jul; 19(7):953-964. PubMed ID: 29866475
[TBL] [Abstract][Full Text] [Related]
60. Polymorphisms in ATP-binding cassette transporter genes and interaction with diet and life style factors in relation to colorectal cancer in a Danish prospective case-cohort study.
Kopp TI; Andersen V; Tjonneland A; Vogel U
Scand J Gastroenterol; 2015; 50(12):1469-81. PubMed ID: 26109419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
